Management of Bell palsy: Clinical practice guideline

CMAJ

Volumn 186, Issue 12, 2014, Pages 917-922

  De Almeida, John R ^a   Guyatt, Gordon H ^b   Sud, Sachin ^c   Dorion, Joanne ^d   Hill, Michael D ^f   Kolber, Michael R ^h   Lea, Jane ^i,j   Loong, Sylvia ^k   Somogyi, Balvinder K ^l   Westerberg, Brian D ^i,j   White, Chris ^g   Chen, Joseph M ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Facial Rehabilitation   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j ST PAUL S HOSPITAL   (Canada)

^k Back in Action Physiotherapy   (Canada)

^l Bell Palsy   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; EYE DROPS; ANTIINFLAMMATORY AGENT;

BELL PALSY; CLINICAL DECISION MAKING; CONFLICT OF INTEREST; CORNEA DISEASE; DECOMPRESSION SURGERY; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; ELECTROSTIMULATION THERAPY; EVIDENCE BASED MEDICINE; EXERCISE; EYE PROTECTION; EYELID CLOSURE; FACE DISORDER; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; OINTMENT; PARESIS; PATIENT ASSESSMENT; PATIENT CARE; PATIENT REFERRAL; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; REVIEW; RISK REDUCTION; THERAPY EFFECT; TREATMENT RESPONSE; WEAKNESS; ARTICLE; MULTIMODALITY CANCER THERAPY;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BELL PALSY; COMBINED MODALITY THERAPY; HUMANS; PHYSICAL THERAPY MODALITIES; REFERRAL AND CONSULTATION;

EID: 84907179972     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.131801     Document Type: Article

References (38)

1. Holland NJ, Weiner GM. Recent developments in Bell's palsy. BMJ 2004;329:553-7.
2. Hauser WA, Karnes WE, Annis J, et al. Incidence and prognosis of Bell's palsy in the population of Rochester, Minnesota. Mayo Clin Proc 1971;46:258-64.
3. Adour KK, Bell DN, Hilsinger RL Jr. Herpes simplex virus in idiopathic facial paralysis (Bell palsy). JAMA 1975;233:527-30.
4. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93:146-7.
5. Ross BG, Fradet G, Nedzelski JM. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg 1996;114:380-6.
6. Peitersen E. The natural history of Bell's palsy. Am J Otol 1982; 4:107-11.
7. Peitersen E. Bell's palsy: the spontaneous course of 2500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002;(549):4-30.
8. Weir AM, Pentland B, Murray J, et al. Bell's palsy: the effect on self-image, mood state and social activity. Clin Rehabil 1995;9:121-5.
9. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
10. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: What is "quality of evidence" and why is it important to clinicians? BMJ 2008;336:995-8.
11. Guyatt GH, Oxman AD, Kunz R, et al. GRADE: going from evidence to recommendations. BMJ 2008;336:1049-51.
12. Guyatt GH, Oxman AD, Kunz R, et al. GRADE: incorporating considerations of resources use into grading recommendations. BMJ 2008;336:1170-3.
13. Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decision on clinical practice guidelines when consensus is elusive. BMJ 2008;337:a744.
14. Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ 2010;182:1045-52.
15. Guyatt G, Akl EA, Hirsh J, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 2010;152:738-41.
16. de Almeida JR, Al Khaboi M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA 2009;302:985-93.
17. Axelsson S, Berg T, Jonsson L, et al. Prednisolone in Bell's palsy related to treatment start and age. Otol Neurotol 2011;32:141-6.
18. Hernández RA, Sullivan F, Donnan P, et al. Economic evaluation of early administration of prednisolone and/or acyclovir for the treatment of Bell's palsy. Fam Pract 2009;26:137-44.
19. Barbara M, Antonini G, Vestri A, et al. Role of Kabat physical rehabilitation in Bell's palsy: a randomized trial. Acta Otolaryngol 2010;130:167-72.
20. Wang XH, Zhang LM, Han M, et al. Clinical application of functional exercise and staged therapy in treatment of facial nerve paralysis [article in Chinese]. Zhonghua Linchuang Kangfu Zazhi 2004;8:616-7.
21. Wen CM, Zhang BC. Effect of rehabilitation training at different degree in the treatment of idiopathic facial palsy: a randomized controlled comparison. Zhongguo Linchuang Kangfu 2004;8:2446-7.
22. Beurskens CHG, Heymans PG. Mime therapy improves facial symmetry in people with long-term facial nerve paresis: a randomized controlled trial. Aust J Physiother 2006;52:177-83.
23. Mosforth J, Taverner D. Physiotherapy for Bell's palsy. BMJ 1958; 2:675-7.
24. Flores PF, Medina RZ, Haro LG. Idiopathic peripheral facial paralysis treatment physic therapy versus prednisone [article in Spanish]. Rev Med Inst Mex Seguro Soc 1998;36:217-21.
25. Manikandan N. Effet of facial neuromuscular re-education on facial symmetry in patients with Bell's palsy: a randomized controlled trial. Clin Rehabil 2007;21:338-43.
26. Alakram P, Puckree T. Effects of electrical stimulation on House-Brackmann scores in early Bell's palsy. Physiother Theory Pract 2010;26:160-6.
27. Gantz BJ, Rubinstein JT, Gidley P, et al. Surgical management of Bell's palsy. Laryngoscope 1999;109:1177-88.
28. Fisch U. Surgery for Bell's palsy. Arch Otolaryngol 1981;107:1-11.
29. Brown JS. Bell's palsy: a 5-year review of 174 consecutive cases: an attempted double blind study. Laryngoscope 1982;92:1369-73.
30. Marzo SJ, Leonetti JP, Petruzzelli G. Facial paralysis caused by malignant skull base neoplasms. Neurosurg Focus 2002;12:e2.
31. Zhang R, Liu JP, Dai C. Misdiagnosis of facial nerve tumor [article in Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007;42:817-20.
32. Raghavan P, Mukherjee S, Phillips CD. Imaging of the facial nerve. Neuroimaging Clin N Am 2009;19:407-25.
33. Schwaber MK, Zealear D, Netterville JL, et al. The use of magnetic resonance imaging with high-resolution CT in the evaluation of facial paralysis. Otolaryngol Head Neck Surg 1989;101:449-58.
34. Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg 2013;149(3 Suppl): S1-27.
35. Grogan PM, Gronseth GS. Practice parameter: steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2001;56:830-6.
36. Gronseth GS, Paduga R. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012;79:2209-13.
37. Lunan R, Nagarajan L. Bell's palsy: a guideline proposal following a review of practice. J Paediatr Child Health 2008;44:219-20.
38. Murthy JM, Saxena AB. Bell's palsy: treatment guidelines. Ann Indian Acad Neurol 2011;14(Suppl 1):S70-2.